Akamis Bio
PrivateLast Round
Series A
Dec 17, 2024
Total Funding Raised
$171.4M
Company Overview
Akamis Bio is a biotechnology company specializing in the development of cancer gene therapies, focusing on immunobiology treatments for solid tumors through its proprietary intravenously administered T-SIGn virus platform to provide effective care for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akamis Bio Comps
Public and private peers based on sector, stage, and business model.
Akamis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 17, 2024 | ||||
| Convertible Debt | Jan 5, 2023 | ||||
| Series C | May 19, 2015 | ||||
| Series B | Jul 9, 2012 | ||||
| VC Round | Dec 15, 2010 | ||||
Series A | Mar 3, 2010 |
Key People
Founding team and executive leadership
Akamis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series B, Series C |
| Westlake Village Biopartners | Convertible Debt |
| IP Group | Convertible Debt |
| Parker Institute for Cancer Immunotherapy | Convertible Debt |
| Woodford Investment Management | Series C |
| ARCH Venture Partners | Convertible Debt |
| Imperial Innovations | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2025
NG-350A receives designation for advanced rectal cancer treatment.
- Aug 12, 2025
Andrew Hirsch appointed to the Board of Directors.
Akamis Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Akamis Bio's valuation, stock price, and market status.
